Fourth Annual: Clinical Application of Cell-Free DNA

In the era of personalised medicine, personalised diagnostics are essential to guide clinicians’ choice of therapies. Cell-free DNA (cfDNA) testing is proving to be a pioneering technology that meets the clinical need of non-invasiveness and ease of use. cfDNA technologies have been maturing rapidly and are continuing to be improved for better sensitivity and specificity. However, experts in the field are still working to establish how to implement these technologies in clinical settings. In this year’s conference, we will focus on emerging clinical applications of cell-free DNA tests, such as longitudinal monitoring of disease progression, assessment of treatment response, and prognosis following curative-intent therapy. We will also address standardization of pre-analytical and analytical methodologies, which is much needed for implementation of cell-free DNA in a clinical context.


More information: